Arcutis Biotherapeutics, Inc. short interest in 2023
In 2023, Arcutis Biotherapeutics, Inc.'s disclosed short interest ran from 17.63% of shares outstanding on 13 Jan 2023 to 21.38% on 29 Dec 2023, a change of +3.75 percentage points. The year's high was 25.27% on 28 Apr 2023 and its low 17.63% on 13 Jan 2023, averaging 21.84% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.94 days on 28 Apr 2023. Full history: Arcutis Biotherapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 17.63% (13 Jan 2023)
- End of year
- 21.38% (29 Dec 2023)
- Change
- +3.75 pp
- High
- 25.27% (28 Apr 2023)
- Low
- 17.63% (13 Jan 2023)
- Average
- 21.84%
- Highest days to cover
- 21.94 (28 Apr 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 17.63% | 12.68 | |
| 31 Jan 2023 | 17.70% | 13.75 | |
| 15 Feb 2023 | 19.50% | 17.19 | |
| 28 Feb 2023 | 20.32% | 16.12 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 22.57% | 9.93 | |
| 31 Mar 2023 | 24.81% | 13.47 | |
| 14 Apr 2023 | 25.19% | 11.98 | |
| 28 Apr 2023 | 25.27% | 21.94 | |
| 15 May 2023 | 24.44% | 10.14 | 10-Q filed, results (8-K) |
| 31 May 2023 | 21.24% | 8.81 | |
| 15 Jun 2023 | 21.31% | 10.75 | |
| 30 Jun 2023 | 23.99% | 8.00 | |
| 14 Jul 2023 | 24.03% | 20.41 | |
| 31 Jul 2023 | 24.76% | 19.19 | |
| 15 Aug 2023 | 25.06% | 19.40 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 20.23% | 9.07 | |
| 15 Sep 2023 | 21.54% | 13.06 | |
| 29 Sep 2023 | 21.06% | 11.95 | |
| 13 Oct 2023 | 22.80% | 7.99 | |
| 31 Oct 2023 | 18.08% | 3.66 | results (8-K) |
| 15 Nov 2023 | 18.56% | 7.56 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 22.14% | 6.81 | |
| 15 Dec 2023 | 20.62% | 5.30 | |
| 29 Dec 2023 | 21.38% | 1.81 |
See also: Arcutis Biotherapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.